Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling

Cost Effectiveness and Resource Allocation

Volumn 9, Issue , 2011, Pages

  Neumann, Anne ^a,b   Schwarz, Peter ^c   Lindholm, Lars ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Decision making; Diabetes mellitus; Early intervention; Health care costs; Health care economics and organisations; Life style; Primary prevention

Indexed keywords

ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HIDDEN MARKOV MODEL; LIFESTYLE INTERVENTION PROGRAM; LIFESTYLE MODIFICATION; LONG TERM CARE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PROBABILITY; QUALITY ADJUSTED LIFE YEAR;

EID: 81255178552     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-9-17     Document Type: Article

References (36)

1. International Diabetes Federation (IDF) IDF Diabetes Atlas. 2009, 4, International Diabetes Federation (IDF).
2. Liebl A. Costs involved in the early and late phases of diabetes mellitus. Internist 2007, 48:708-714. 10.1007/s00108-007-1875-0, 17576527.
3. Robert Koch-Institut Heft 24 - Diabetes Mellitus. Gesundheitsberichterstattung des Bundes 2005, 36. Robert Koch-Institut.
4. Kulzer B, Hermanns N, Gorges D, Schwarz P, Haak T. Prevention of Diabetes Self-Management Program (PREDIAS): Effects on Weight, Metabolic Risk Factors, and Behavioral Outcomes. Diabetes Care 2009, 32(7):1143-1146. 10.2337/dc08-2141, 2699739, 19509014.
5. Saha S, Gerdtham UG, Johansson P. Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases. Int J Environ Res Public Health 2010, 7:3150-3195. 10.3390/ijerph7083150, 2954575, 20948954.
6. Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada. Diabet Med 2004, 21(11):1229-1236. 10.1111/j.1464-5491.2004.01330.x, 15498090.
7. Dalziel K, Segal L. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions. Health Promotion International 2007, 22(4):271-283. 10.1093/heapro/dam027, 17916604.
8. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 2008, 336(7654):1180-1185. 10.1136/bmj.39545.585289.25, 2394709, 18426840.
9. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998, 13(4):397-409. 10.2165/00019053-199813040-00003, 10178664.
10. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics 2000, 17(5):461-477. 10.2165/00019053-200017050-00005, 10977388.
11. Rose G, Khaw K-T, Marmot M. Rose's Strategy of Preventive Medicine 1992, Oxford University Press, USA.
12. Eriksson K, Westborg C, MC E. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors. Scand J Public Health 2006, 34:453-461. 10.1080/14034940500489826, 16990155.
13. Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Polonen A, Rissanen A, et al. Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res 2010, 42(Suppl 1):S37-55.
14. Paulweber B, Valensi P, Lindstrom J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010, 42(Suppl 1):S3-36.
15. Schwarz PE, Li J, Reimann M, Schutte AE, Bergmann A, Hanefeld M, Bornstein SR, Schulze J, Tuomilehto J, Lindström J. The Finnish Diabetes Risk Score is Associated with Insulin Resistance and Progression towards Type 2 Diabetes. J Clin Endocrinol Metab 2009, 94(3):920-926.
16. Schwarz PE, Schwarz J, Schuppenies A, Bornstein SR, Schulze J. Development of a diabetes prevention management program for clinical practice. Public Health Rep 2007, 122(2):258-263. 1820432, 17357369.
17. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation 2007, Oxford University Press, USA.
18. Neumann A. Assessing the cost-effectiveness of the Saxon Diabetes Type 2 Prevention Program Using a Markov Model. Master thesis in public health (2009:1) 2009, Umeå International School of Public Health. Epidemiology and Public Health Sciences, dept of Public Health and Clinical Medicine, Umeå University., http://www.phmed.umu.se/enheter/epidemiologi/forskning/publikationer/public-health-report-series/#2009
19. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet 2006, 368:1673-1679.
20. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350. 10.1056/NEJM200105033441801, 11333990.
21. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003, 46(2):182-189.
22. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet 2008, (371):1783-1789.
23. Statistik der Sterbefälle, Fortschreibung des Bevölkerungsstandes: Gestorbene je 100,000 Einwohner in Sachsen 2005 und 2006 nach Alter und Geschlecht Indikator (K) 3.6. Statistisches Landesamt des Freistaates Sachsen 2008,
24. Boyko EJ. Progress in the estimation of mortality due to diabetes. Diabetes Care 2005, 28(9):2320-2321. 10.2337/diacare.28.9.2320, 16123511.
25. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005, 28(9):2130-2135. 10.2337/diacare.28.9.2130, 16123478.
26. Statistisches Bundesamt Preise: Verbraucherpreisindizes für Deutschland. Volume Fachserie 17, Reihe 7 2010, 100. Wiesbaden: Statistisches Bundesamt, Statistisches Bundesamt.
27. Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther 2004, 26(2):304-321. 10.1016/S0149-2918(04)90029-X, 15038953.
28. Kontodimopoulos N, Pappa E, Papadopoulos AA, Tountas Y, Niakis D. Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual Life Res 2009, 18:87-97. 10.1007/s11136-008-9420-8, 19051058.
29. Altman DG, Bland JM. Standard deviations and standard errors. BMJ 2005, 331(7521):903. 10.1136/bmj.331.7521.903, 1255808, 16223828.
30. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG) Technical Document - Modelling, Version 1.0. 2008, Köln: IQWIG, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG).
31. Bravo Y, Sculpher M. Making decisions under uncertainty - the role of probabilistic decision modelling. Family Practice 2006, 23:391-392. 10.1093/fampra/cml037, 16837481.
32. Drummond M, McGuire A. Economic Evaluation in Health Care - Merging theory with practice 2001, Oxford University Press.
33. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes 2005, Oxford University Press, Third.
34. Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care. Am J Epidemiol 2009, 169(5):562-571.
35. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002, 25(3):458-463. 10.2337/diacare.25.3.458, 11874930.
36. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005, 142(5):323-332. 2701392, 15738451.